本文選題：腦卒中 + 血管性認(rèn)知障礙�。� 參考：《黑龍江中醫(yī)藥大學(xué)》2014年碩士論文

【摘要】：目的：觀察認(rèn)知功能訓(xùn)練對腦卒中后血管性認(rèn)知障礙(vascular cognitive impairment VCI)患者認(rèn)知功能及日常生活活動能力的影響 方法：臨床研究共納入60例VCI患者,隨機(jī)分為2組,實驗組與對照組,每組各30例。對照組給予入院基礎(chǔ)治療、針灸治療、口服日常治療量尼莫地平治療；治療組在對照組基礎(chǔ)上給予患者認(rèn)知功能訓(xùn)練。兩組均以8周為治療周期,結(jié)束后觀察兩組患者蒙特利爾認(rèn)知評估量表(montreal cognitive assessment, MoCA)、簡易智能精神狀態(tài)量表(mini mental state examination,MMSE)、日常生活能力(activity of daily life,ADL)的評分變化情況。 結(jié)果： 1.治療組治療前后MoCA評分經(jīng)t檢驗P0.05,存在顯著統(tǒng)計學(xué)差異；對照組治療前后MoCA評分經(jīng)t檢驗P0.05,存在統(tǒng)計學(xué)差異；治療組與對照組治療后MoCA評分經(jīng)t檢驗P0.05,存在顯著統(tǒng)計學(xué)差異。兩種治療方法對于VCI患者的MoCA評分均有改善作用,但治療組優(yōu)于對照組。 2.治療組治療前后MMSE評分經(jīng)t檢驗P0.05,存在顯著統(tǒng)計學(xué)差異；治療組與對照組治療后MMSE評分經(jīng)t檢驗P0.05,存在統(tǒng)計學(xué)差異。在MMSE評分改善方面,治療組明顯優(yōu)于對照組 3.治療組治療前后ADL評分經(jīng)t檢驗P0.05,存在顯著統(tǒng)計學(xué)差異；治療組與對照組治療后ADL評分經(jīng)t檢驗P0.05,存在統(tǒng)計學(xué)差異。在改善VCI患者ADL評分上,治療組優(yōu)于對照組。 結(jié)論：認(rèn)知功能訓(xùn)練可有效改善腦卒中后血管性認(rèn)知障礙患者的認(rèn)知功能及日常生活活動能力。
[Abstract]:Objective: to observe the effect of cognitive function training on cognitive function and activities of daily living (ADL) in patients with vascular cognitive impairment (VCI) after stroke. Methods: 60 patients with VCI were randomly divided into two groups. There were 30 cases in each group. The control group was treated with admission basic treatment, acupuncture treatment, oral daily treatment of nimodipine, while the treatment group was given cognitive function training on the basis of the control group. The two groups were treated for 8 weeks. After the end, the scores of the Montreal cognitive Assessment scale (MCA), the mini mental state examination (MMSE) and the activity of daily Life (ADL) were observed. Results: 1. There was significant difference in MoCA score before and after treatment between the treatment group and the control group by t test (P0.05), the MoCA score before and after treatment in the control group was significantly different from that in the control group by t test (P0.05), and there was significant difference in the MoCA score between the treatment group and the control group by t test (P0.05). The two treatments improved the MoCA score of VCI patients, but the treatment group was better than the control group. 2. There was significant difference in MMSE score before and after treatment between the treatment group and the control group by t test (P 0.05), and there was statistical difference between the treatment group and the control group after treatment (P 0.05). The improvement of MMSE score in the treatment group was significantly better than that in the control group. Before and after treatment, there was significant difference in ADL score between treatment group and control group by t test (P0.05), and there was statistical difference between treatment group and control group after treatment (P0.05). In improving the ADL score of VCI patients, the treatment group was superior to the control group. Conclusion: cognitive function training can effectively improve the cognitive function and activities of daily living in patients with vascular cognitive impairment after stroke.
【學(xué)位授予單位】：黑龍江中醫(yī)藥大學(xué)
【學(xué)位級別】：碩士
【學(xué)位授予年份】：2014
【分類號】：R743.3;R49

【參考文獻(xiàn)】

相關(guān)期刊論文 前10條

1 黃凡;劉悅;周飛雄;姚國新;賀清濤;;針刺對腦梗死后血管性認(rèn)知障礙的影響[J];廣東醫(yī)學(xué);2008年11期

2 楊毅娟;楊雁;;通竅活血湯對血管性癡呆患者認(rèn)知功能的改善[J];北方藥學(xué);2013年10期

3 蘇志偉;賈愛芬;徐榮栓;;益腎通督法治療血管性非癡呆的認(rèn)知功能損害50例療效觀察[J];河北中醫(yī);2010年10期

4 賈建平;江漢秋;;進(jìn)一步重視血管性癡呆的防治[J];內(nèi)科理論與實踐;2007年02期

5 闞魯;;安理申聯(lián)合腦心康治療血管性認(rèn)知障礙的療效評估[J];內(nèi)蒙古中醫(yī)藥;2013年12期

6 李國林;;復(fù)方丹參注射液與黃芪注射液聯(lián)合治療血管性癡呆臨床研究[J];內(nèi)蒙古中醫(yī)藥;2013年19期

7 翟廣琪;;益氣聰明湯治療血管性癡呆30例[J];河南中醫(yī);2013年11期

8 駱迪;畢齊;;血管性認(rèn)知功能障礙研究進(jìn)展[J];中國全科醫(yī)學(xué);2011年35期

9 湯湘江,老膺榮,楊志敏,黃培新,雒曉東;補腎活血湯加減治療血管性癡呆的臨床研究[J];廣州中醫(yī)藥大學(xué)學(xué)報;2005年06期

10 黃凡;鄺偉川;周飛雄;姚國新;陸彥青;;飛經(jīng)走氣針法對腦梗死后血管性認(rèn)知障礙的影響[J];上海針灸雜志;2011年02期

，

本文編號：2013590